N
Nykode Therapeutics ASA
OTC:VACBF
Nykode Therapeutics ASA
OTC:VACBF
Price:
0.3542
USD
Market Cap:
$115.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Nykode Therapeutics ASA
OTC:VACBF
|
NO |
|
China BlueChemical Ltd
OTC:CBLUY
|
CN |
|
Mokingran Jewellery Group Co Ltd
F:0HY
|
CN |
|
J
|
Jungheinrich AG
SWB:JUN3
|
DE |
|
SuRo Capital Corp
NASDAQ:NSLR
|
US |
|
J
|
JDC Corp
F:JDD
|
JP |
|
C
|
Charbone Hydrogen Corp
F:K47
|
CA |
|
Babylon Holdings Ltd
F:7UK0
|
US |
|
S
|
Sapiens International Corporation NV
F:S3P
|
IL |
|
C
|
Centogene NV
F:39K
|
DE |
|
F
|
Far East Consortium International Ltd
XBER:FET
|
HK |
|
Tianjin Jinran Public Utilities Co Ltd
F:TL6
|
CN |
|
MVB Financial Corp
F:MV6
|
US |
Wall St Price Targets
VACBF Price Targets Summary
Nykode Therapeutics ASA
Nykode Therapeutics ASA
Wall Street analysts forecast VACBF stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for VACBF is 0.4005 USD with a low forecast of 0.3569 USD and a high forecast of 0.4535 USD.
Lowest Forecast
Price Target
0.3569
USD
1% Upside
Average Forecast
Price Target
0.4005
USD
13% Upside
Highest Forecast
Price Target
0.4535
USD
28% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VACBF's stock price target?
Price Target
0.4005
USD
0.4005
USD
According to Wall Street analysts, the average 1-year price target for VACBF is 0.4005 USD with a low forecast of 0.3569 USD and a high forecast of 0.4535 USD.
